isoproterenol has been researched along with amifostine anhydrous in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Conger, AD; Samel, A; Sodicoff, M | 1 |
| Conger, AD; Sodicoff, M | 1 |
| Miller, EG; Taylor, SE | 1 |
2 review(s) available for isoproterenol and amifostine anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Preemptive pharmacologic intervention in radiation-induced salivary dysfunction.
Topics: Adrenergic beta-Agonists; Amifostine; Animals; Head and Neck Neoplasms; Humans; Iatrogenic Disease; In Vitro Techniques; Isoproterenol; Muscarinic Agonists; Pilocarpine; Radiation Injuries; Radiation Tolerance; Radiation-Protective Agents; Salivary Glands; Transplantation Conditioning; Whole-Body Irradiation; Xerostomia | 1999 |
3 other study(ies) available for isoproterenol and amifostine anhydrous
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of cAMP with other radioprotectors against chronic damage to the rat parotid gland.
Topics: Amifostine; Animals; Cyclic AMP; Female; Isoproterenol; Parotid Gland; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Inbred Strains; Time Factors | 1985 |
Radioprotection of the rat parotid gland by WR-2721 and isoproterenol and its modification by propranolol.
Topics: Amifostine; Animals; Dose-Response Relationship, Radiation; Drug Interactions; Isoproterenol; Organ Size; Organothiophosphorus Compounds; Parotid Gland; Propranolol; Radiation Tolerance; Rats; Rats, Inbred Strains; X-Rays | 1983 |